ClinicalTrials.gg
RecruitingNCT06368089Updated Nov 6, 2024

Short Effects of SIMT and EM in Prolonged Mechanically Ventilated Patients

An interventional study of Inspiratory muscle training (IMT) group and Early mobilization (EM) group in Ventilator Dependent, sponsored by Prince of Songkla University. Recruiting at 1 site in Thailand. Open to participants aged 40 Years to 80 Years. Per ClinicalTrials.gov, last updated 2024-11-06.

Sponsored by Prince of Songkla University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Feb 2026, 9 months ago, but the record still lists the study as recruiting.
  • Started May 2024; still recruiting 2 years 6 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
46
Allocation
Randomized
Ages
40 Years to 80 Years
Sex
All
01

Study summary

Using mechanical ventilation for more than 18 hours can affect respiratory muscle and postural muscle control, making it difficult to wean off the ventilator and reducing mobility. The aim of this study is to:

  1. Compare the effects of respiratory muscle strength training and early mobilization on dynamic lung compliance and maximum inspiratory pressure before and after a 7-day training period.
  2. Compare the success rate of weaning and the duration of weaning between the respiratory muscle strength training and the early mobilization program.
Read the detailed description

The prolonged mechanical ventilation results in difficulty weaning off the ventilator. Inspiratory muscle strength and early mobilization can contribute to the expansion of lung parenchyma and facilitate success in weaning off respiratory support. Thus, this study aimed to explain the impact of inspiratory muscle training and early mobilization on dynamic lung compliance, spontaneous breathing time, and success rate in patients who have undergone mechanical ventilation for more than 48 hours.

02

Conditions studied

  • Ventilator Dependent

Keywords

  • Specific inspiratory muscle training
  • Early mobilization
  • Lung compliance
  • Prolong mechanical ventilation
  • Weaning outcome
03

In context

Lead sponsor

Prince of Songkla University is the lead sponsor of 116 studies on the registry; 13 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with respiratory diseases who have been on mechanical ventilation for more than 48 hours and are ready to be weaned off or undergoing weaning trials with continuous positive airway pressure (CPAP) or synchronized intermittent mandatory ventilation (SIMV).
  • The PaO2/FiO2 ratio is ≥ 150-200, with FiO2 ≤ 0.4-0.5 and PEEP ≤ 5-8 cmH2O, and a pH > 7.3 in blood plasma.
  • The age range is between 40 and 80 years old.
  • Patients exhibit good self-awareness and cooperation in training (Riker score of 4).
  • They can understand and communicate in Thai

Exclusion criteria

Exclusion Criteria:

  • Clinical instability (HR > 120 beats/minute, RR > 30 breaths/minute, SatO2 \< 90%, SBP > 140 mmHg or \< 90 mmHg)
  • Patients who can be extubated and use non-invasive ventilation only or successfully extubated within the first 24 hours.
  • Patients with altered mental status (Glasgow Coma Score \< 10) and inability to cooperate with training (Riker score \< 4 or > 4)
  • Patients with limitations or such as inability to adjust the bed to a 45-degree angle or sit on the side of the bed, such as those with spinal cord injuries or recent head surgeries.
  • History of hemoptysis, pneumothorax
  • History of neuromuscular diseases causing muscle weakness and decreased sensation.
  • Patients with excessive cardiac stimulation (> 5 micrograms per kilogram per minute)
  • Heart rate > 140 beats per minute
  • levels \< 8-10 grams per deciliter
  • Patients with difficult airway issues.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

Hemoglobin (Hb)

The protein in red blood cells that carries oxygen. A low level is anemia, which can cause tiredness and breathlessness. Measured in g/dL or g/L (9 g/dL is 90 g/L).

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
46 participants (estimated)

Study arms

  • Experimental
    IMT group

    Inspiratory muscle training group

    Other: Inspiratory muscle training (IMT) group

  • Active comparator
    EM group

    Early mobilization group

    Other: Early mobilization (EM) group

Interventions

  • OtherInspiratory muscle training (IMT) group

    The IMT group receives inspiratory muscle training of 50%MIP, 6 breaths/set 10 sets/day for 7 days combined with conventional chest physiotherapy including; percussion, vibration, postural draining, positioning, and passive range of motion.

  • OtherEarly mobilization (EM) group

    The ER group received active exercise in sitting, standing, and marching 30 minutes/day for 7 days with conventional chest physical therapy

06

What researchers measure

Primary outcomes

  1. Maximum inspiratory pressure (MIP)

    MIP measurement using manometer, the device can be attached directly to the ETT or tracheostomy tube, and measures the pressure generated by patient on inhalation against a closed system.

    Time frame: baseline and day 7 after program

  2. Dynamic lung compliance (Cdyn)

    Dynamic lung compliance refers to the ratio of the change in volume to the change in pressure over a tidal breath, with the pressure measured at moments of zero flow during breathing that recording from the mechanical ventilation

    Time frame: baseline and day 7 after program

Secondary outcomes

  1. Weaning time

    Duration of weaning time (hour)

    Time frame: baseline and day 7 after program

  2. Weaning outcome

    measure weaning success rate

    Time frame: baseline and day 7 after program

  3. Grip strength

    using hand grip dynamometer

    Time frame: baseline and day 7 after program

  4. chest wall expansion

    measure by using tape at the axillary, xiphoid process, and umbrilical level

    Time frame: baseline and day 7 after program

07

Study locations

1 of 1 sites recruiting
  • Medical Respiratory Care Unit (MRCU), Prince of Songklanakarind Hospital
    Songkhla, 90110, Thailand
    Recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started May 2024 (actual). Primary completion is estimated for Feb 2026, 21 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 1, 2024
First posted
Apr 16, 2024
StartActual
May 6, 2024
Primary completionEst.
Feb 2026
CompletionEst.
Mar 2026
Last update
Nov 6, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 6, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06368089
Responsible party
Saikaew Chuachan (Department of Physical Therapy, Faculty of Medicine, Prince of Songkla University) — Principal investigator
First posted
Apr 16, 2024
Start date
May 6, 2024
Primary completion
Feb 2026 (estimated)
Completion
Mar 2026 (estimated)
Last update
Nov 6, 2024

Study contacts

Saikaew Chuachan, Msc.PT
Contact
saikaew.ch@psu.ac.th
0849988665
Saikaew Chuachan
principal investigator · Department of Physical Therapy, Faculty of Medicine, PSU
Natcha Kimthiaw, Bsc.PT
study director · Department of Physical Therapy, Faculty of Medicine, PSU
Luksamee Kaewchano, Bsc.PT
study director · Department of Physical Therapy, Faculty of Medicine, PSU
Ittiphon Pannarai, Bsc.PT
study director · Department of Physical Therapy, Faculty of Medicine, PSU
Jatuporn Jaturawanit, Bsc.PT
study director · Physical Therapy unit, Songklanakarind Hospital
Jitsupa Kittarakul, Bsc.PT
study director · Physical Therapy unit, Songklanakarind Hospital
Boonmas Chansirimongkol, B.N.S.
study director · Medical Respiratory Care Unit, Prince of Songklanakarind Hospital
Kwankamol Kalsri, B.N.S
study director · Medical Respiratory Care Unit, Prince of Songklanakarind Hospital
Assoc.Prof.Siwasak Juthong, MD
study director · Division of Respiratory and Respiratory Critical Care Medicine, Department of Internal Medicine, PSU

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion